RSBN1 is a histone demethylase that specifically removes methyl groups from histone H4 at lysine 20, converting H4K20me2 and H4K20me3 to H4K20me1 to modulate chromosome 1. The protein is expressed exclusively in round spermatids during spermatogenesis, where it localizes to the nucleus and is phosphorylated by protein kinase A, suggesting a role in transcriptional regulation during haploid germ cell differentiation 1. RSBN1 lies in the 1p13.2 chr1 region alongside PTPN22 and other genes implicated in shared genetic mechanisms across multiple diseases. A pleiotropic genome-wide association study identified the 1p13.2 locus—including RSBN1—as regulating both bone mineral density and rheumatoid arthritis risk simultaneously 2. RSBN1 has also emerged in expression studies as a target of microRNA-378d in vitamin D-deficient states, where its downregulation correlates with altered glucose homeostasis in ovarian granulosa cells 3. Recent functional studies identified RSBN1 as a novel oncogenic target in cervical cancer associated with human papillomavirus integration events, demonstrating tumor-promoting properties in cell migration and proliferation assays 4. These findings suggest RSBN1 participates in multiple regulatory networks extending beyond spermatogenesis into immune, metabolic, and oncogenic contexts.